Upstream Bio Q3 Sales $607.00K Down From $621.00K YoY, Completed Upsized IPO With Gross Proceeds Of Approximately $293M, Extending Runway Through 2027
Upstream Bio Q3 Sales $607.00K Down From $621.00K YoY, Completed Upsized IPO With Gross Proceeds Of Approximately $293M, Extending Runway Through 2027
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.